Protalix BioTherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PLX and other ETFs, options, and stocks.About PLX
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11.
CEODror Bashan
CEODror Bashan
Employees213
Employees213
HeadquartersHackensack, New Jersey
HeadquartersHackensack, New Jersey
Founded1993
Founded1993
Employees213
Employees213
PLX Key Statistics
Market cap179.40M
Market cap179.40M
Price-Earnings ratio32.16
Price-Earnings ratio32.16
Dividend yield—
Dividend yield—
Average volume650.34K
Average volume650.34K
High today$2.39
High today$2.39
Low today$2.24
Low today$2.24
Open price$2.35
Open price$2.35
Volume306.27K
Volume306.27K
52 Week high$3.10
52 Week high$3.10
52 Week low$1.16
52 Week low$1.16
Stock Snapshot
As of today, Protalix BioTherapeutics(PLX) shares are valued at $2.25. The company's market cap stands at 179.4M, with a P/E ratio of 32.16.
On 2025-11-06, Protalix BioTherapeutics(PLX) stock traded between a low of $2.24 and a high of $2.39. Shares are currently priced at $2.25, which is +0.4% above the low and -5.9% below the high.
Protalix BioTherapeutics(PLX) shares are trading with a volume of 306.27K, against a daily average of 650.34K.
In the last year, Protalix BioTherapeutics(PLX) shares hit a 52-week high of $3.10 and a 52-week low of $1.16.
In the last year, Protalix BioTherapeutics(PLX) shares hit a 52-week high of $3.10 and a 52-week low of $1.16.
People also own
Based on the portfolios of people who own PLX. This list is generated using Robinhood data, and it’s not a recommendation.